netFormulary NHS
Shropshire and Telford Local Health Economy
Shropshire, Telford and Wrekin CCG
Shrewsbury and Telford Hospitals NHS Trust
Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust
Shropshire Community Health NHS Trust
 Search
 Formulary Chapter 4: Central nervous system - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
04.01.01 Hypnotics (2,0)
Benzodiazepines (1,0)
Zolpidem and Zopiclone (2,0)
Chloral and derivatives (2,0)
Antihistamines (1,0)
Sodium oxybate (0,1)
04.01.02 Anxiolytics (0,0)
Benzodiazepines (3,0)
04.02.01 Antipsychotic Drugs (4,0)
First-Generation Antipsychotic Drugs (2,0)
Second-Generation Antipsychotic Drugs (7,0)
04.02.02 Antipsychotic depot injections (7,0)
04.02.03 Drugs used for mania and hypomania (2,0)
Antipsychotic drugs (5,0)
Carbamazepine (1,0)
Valproic acid (1,0)
Lithium (3,0)
04.03.01 Tricyclic and related antidepressant drugs (0,0)
Tricyclic antidepressants (4,2)
04.03.02 Monoamine-oxidase inhibitors (1,0)
Reverible MAOIs (1,0)
04.03.03 Selective serotonin re-uptake inhibitors (7,0)
04.03.04 Other antidepressant drugs (2,0)
04.04 CNS stimulants and other drugs used for attention deficit hyperactivity disorder (6,0)
04.05.01 Anti-obesity drugs acting on the gastro-intestinal tract (1,0)
04.06 Drugs used in nausea and vertigo (1,0)
Antihistamines (3,0)
Phenothiazines and related drugs (3,0)
Domperidone and metoclopramide (2,0)
5HT3 antagonists (2,0)
Neurokinin receptor antagonist (1,0)
Hyoscine (1,0)
Other drugs for Ménière's disease (1,0)
04.07.01 Non-opioid analgesics and compound analgesic preparations (0,0)
Compound analgesic preparations (7,1)
04.07.02 Opioid analgesics (11,1)
04.07.03 Neuropathic pain (5,0)
Postherpetic neuralgia (1,0)
04.07.04.01 Treatment of the acute migraine attack (0,0)
5HT1 agonists (2,0)
04.07.04.02 Prophylaxis of migraine (7,0)
04.08.01 Control of epilepsy (0,0)
Carbamazepine and Oxcarbazepine (3,0)
Ethosuximide (1,0)
Gabapentin and pregabalin (2,0)
Lacosamide (1,0)
Lamotrigine (1,0)
Levetiracetam and brivaracetam (2,0)
Perampanel (1,0)
Phenobarbital and other barbiturates (1,0)
Phenytoin (1,0)
Cannabis based products for medicinal use (CBPM) (0,1)
Topiramate (1,0)
Valproate (3,0)
Vigabatrin (1,0)
Zonisamide (1,0)
Benzodiazepines (2,0)
Other Drugs (1,0)
04.08.02 Drugs used in status epilepticus (7,0)
04.08.03 Febrile convulsions (1,0)
04.09.01 Dopaminergic drugs used in Parkinsons disease (1,0)
Dopamine receptor agonists (5,0)
Levodopa (3,0)
Monoamine-oxidase-B inhibitors (2,0)
Catachol-O-methyltransferase inhibitors (2,0)
Amantadine (1,0)
04.09.02 Antimuscarinic drugs used in parkinsonism (2,0)
04.09.03 Drugs used in essential tremor, chorea, tics, and related disorders (3,0)
Torsion dystonias and other involuntary movements (3,0)
04.10.01 Alcohol dependence (2,0)
04.10.02 Nicotine dependence (1,2)
04.10.03 Opioid dependence (0,0)
Opioid substitution therapy (3,0)
Adjunctive therapy and symptomatic treatment (1,0)
Opioid-receptor antagonists (1,0)
04.11 Drugs for dementia (4,0)
netFormulary